Clinical Trials Logo

Clinical Trial Summary

Study Design: Prospective, single-blinded, multi-center, randomized, controlled, pivotal study Study Objective: To evaluate if P-15L is not inferior in effectiveness and safety to local autologous bone (and allograft as extender where necessary) when applied in instrumented TLIF in subjects with Degenerative disc disease (DDD)

Study Endpoints:

Primary endpoint: Month 24 Composite Clinical Success (CCS):

- Achievement of fusion (Evidence of continuous trabecular bridging bone in the intervertebral space)

- At least 15-point improvement in Oswestry Disability Index (ODI)

- No new or worsening, persistent neurological deficit

- No subsequent surgical intervention at the index level

Once fusion is radiographically confirmed, it will be assumed that fusion has occurred at all subsequent time points without the need to reconfirm fusion status at later time points.

Multiplicity Controlled Secondary endpoint:

• Visit at which fusion is confirmed.

Other Secondary endpoints:

- Visual Analog Scale (VAS) pain scores, changes over time, and achievement of a 20 mm improvement (Back, left leg, right leg);

- Physical Function and Mental Health Composite Scores (Short Form Health Survey SF-12 and changes over time).


Clinical Trial Description

Cerapedics currently markets a peptide-enhanced bone graft product, i-FACTOR putty, for use in cervical spine degenerative disk disease. i-FACTOR putty is a composite bone substitute material consisting of the P-15 peptide adsorbed onto anorganic bone mineral and suspended in an inert biocompatible hydrogel carrier. P-15 is a synthetic, 15-amino acid peptide that mimics the cellbinding domain of Type I collagen and is able to signal a mechanical and biochemical communication pathway that ultimately results in new bone formation. The P-15 peptide enhances cell migration and induces osteoblast cell proliferation and differentiation. P-15 is specific to anchoring-dependent connective tissue mesenchymal cells, including osteogenic cells,and therefore does not induce bone formation in the absence of these cells. The receptor mediated anchorage of osteoblasts by P-15 initiates a number of signal transduction pathways that lead to the synthesis of growth factors, cytokines, and bone morphogenetic proteins.

A prospective, randomized, controlled, multi-center clinical trial in cervical spinal fusion demonstrated the safety and efficacy of i-FACTOR putty compared to standard-of-care autograft (clinicaltrials.gov NCT00310440.) The results demonstrated that i-FACTOR putty was statistically non-inferior to autograft for fusion success, improvement in Neck Disability Index (NDI) scores, neurological success and number of adverse events, at both the 1 and 2 year time point. The i-FACTOR putty was demonstrated to be statistically superior to autograft, at both 1 year and 2-years, for "overall success" which measures the patients that were successful in all of the test modalities.

Cerapedics is developing a new bone graft product formulation to enhance our product portfolio, specifically a P15-based bone graft that is appropriate for lumbar spinal fusion, called P-15L. The new formulation comprises two new materials as compared to the original i-FACTOR putty. The first is the use of porcine-derived anorganic bone mineral (ABM) as the anorganic bone matrix. The second modification is the use of bovine collagen as the inert carrier for the anorganic bone granules. The introduction of collagen as the inert carrier will allow the P-15L to be used in a TLIF surgical indication since the collagen component provides material integrity for the putty in the implant site. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03502057
Study type Interventional
Source Northwestern University
Contact Surabhi Bhatt, BS
Phone 312-472-6024
Email surabhi.bhatt@nm.org
Status Recruiting
Phase N/A
Start date August 1, 2018
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Completed NCT04057235 - Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Active, not recruiting NCT02969616 - Trinity Elite in Lumbar Fusion
Completed NCT02558621 - New Robotic Assistance System for Spinal Fusion Surgery N/A
Completed NCT02104167 - Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Completed NCT00965380 - Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Completed NCT00758719 - Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
Completed NCT00165893 - Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease Phase 4
Terminated NCT01494493 - Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04849429 - Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain Phase 1
Recruiting NCT04469387 - Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion N/A
Recruiting NCT04056520 - Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System
Completed NCT04119466 - Stabilizing Training in Degenerative Disc Disease N/A